Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Human Challenge Study to Evaluate Innate and Adaptive Immune Responses to a Controlled Human Infection With BCG Administered by the Intradermal or Aerosol Inhaled Route in Healthy, BCG-naïve or Historically BCG-vaccinated, UK Adult Volunteers

NCT03912207 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT03912207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03912207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Human Challenge Study to Evaluate Innate and Adaptive Immune Responses to a Controlled Human Infection With BCG Administered by the Intradermal or Aerosol Inhaled Route in Healthy, BCG-naïve or Historically BCG-vaccinated, UK Adult Volunteers
Lead sponsor
University of Oxford
Phase
Phase 1
Overall status
Unknown status
Start date
April 19, 2019
Completion date
June 30, 2024
Enrollment
94 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis